Need for Optimal Design of Pharmaceutical Programs and Portfolios in Modern Medical Product Development -- Clinical Aspects of Pharmaceutical Portfolio Management -- Drug Development and the Cost of Capital -- Investment Considerations for Pharmaceutical Product Portfolios -- Challenges of...

Endogene Sunk Costs und die Kostenstruktur -- Endogene Sunk Costs in einem „Love of Variety“ Modell -- Endogene Sunk Costs in einem „Ideal Variety“ Modell -- Anwendungen der Modelle mit endogenen Sunk Costs -- Schlussbemerkungen.